Eric Ducournau
Pierre Fabre Group CEO
EDITORIAL
This pharmacy platform, created for pharmacists, shares the Pierre Fabre group’s expertise and convictions, in total coherence with its core mission: with every single person we care for, we make the world a better place.
Each year in the world, several million people find out that they have cancer. For a long time, this meant a final verdict, but today it is part of a new perspective: cancer is becoming a chronic illness.
60 YEARS
of pharmaceutical expertise, inventor of dermo-cosmetics
Inventor of dermo-cosmetics in 1974, Pierre Fabre created and developed dermo-cosmetic skincare products, combining action in favor of health and the beauty of skin and hair.
In 1981, the meeting between Mr. Pierre and Professor Pierre Potier was a decisive step in the Group’s oncology focus. Impressed by Professor Potier's scientific stature, with whom he shared a deep respect for nature, Pierre Fabre agreed to launch the clinical development and industrialization of vinorelbine – which has a powerful anti-tumor activity. The molecule obtained an MA in April 1989.
On 23 December 1994, it became the first French anti-cancer drug registered in the United States.
OUR MISSION
To care for life by imagining and developing innovative solutions inspired by consumers and patients and contributing to the well-being of everyone – from health to beauty.
This mission is carried out in conjunction with healthcare professionals, who are truly trusted partners wherever the Group operates. How?
-
By drawing on nature and plants as a constant source of inspiration
-
By collaborating with researchers and innovators worldwide
-
By placing pharmaceutical ethics at the heart of our actions
As with all cancers, we know how important it is for healthcare professionals working on skin diseases to have access to the right information at the right time. That is why the United Against Cancers program is divided into three pillars, each fulfilling a specific need.
PREVENT
Help people protect themselves against skin cancers and actinic keratosis.
TREAT
Provide therapeutic solutions to treat melanoma, actinic keratosis, and adverse effects.
ASSIST
Provide tools to educate and support patients.
PSYCHOLOGY
IN ONCO TREATMENTS